NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM201972 Query DataSets for GSM201972
Status Public on Jan 01, 2010
Title RAW 264.7 – infected with Brucella ovis for 4hrs – replicate date 08122003
Sample type RNA
 
Source name RAW 264.7, infected with Brucella ovis, 4 hours
Organism Mus musculus
Characteristics designation: RAW 264.7 macrophages
atcc: TIB-71
growth properties: adherent
tissue: Abelson murine leukemia virus-induced tumor
antigen expression: H-2d
strain: BALB/c mice
bacteria: Brucella ovis, Gram negative, facultative intracellular pathogen
Biomaterial provider American Type Culture Collection (ATCC), G. Splitter Stock Cultures
Treatment protocol RAW 264.7 cells for microarray were plated in 75cm2 flasks 12-24hr prior to infection, in supplemented RPMI 1640 without antibiotics at an approximate concentration of 5x 10^6 cells per flask. Macrophage cells were washed once with PBS prior to infection and 5 mL fresh media added. One mL of actively growing Brucella culture was added to the macrophages (MOI ~1000:1). Infections were allowed to incubate for 4 hours at 37°C with 5% CO2. Cells were washed once with PBS to remove extracellular bacteria and then cells were lysed for RNA collection (RNeasy Mini Kit (Qiagen, Valencia, CA)).
Growth protocol RAW 264.7 (TIB-71, ATCC) mouse macrophage (Mφ) cell line was maintained at 37°C with 5% CO2 in RPMI 1640 (Invitrogen) supplemented with 10% Fetal Bovine Serum, 0.2mM L-glutamine, antibiotic-antimycotic (100 U/mL penicillin G, 100 μg/mL streptomycin, 0.25 μg/mL amphotericin B, Gibco), 1mM sodium pyruvate (SAFC Biosciences), and MEM amino acids (Hyclone). Macrophages were subcultured as necessary by removing old media, washing with PBS, adding fresh media, scraping cells and diluting cells 1:3 to 1:20.
B. melitensis, B. neotomae, B. ovis were grown in 12- by 75-mm tubes on a shaker platform in BBL Brucella broth (BD Bioscience). Cultures for infection were grown at 37°C for 2 days prior to infection.
Extracted molecule total RNA
Extraction protocol Total RNA was isolated from macrophage cultures utilizing RNeasy Mini Kit (Qiagen) according to manufacturer’s protocol with the following modifications. Cells were lysed in RLT and then centrifuged to remove intact bacterial cells. RNA from two independent infections was pooled for each target preparation. DNase treated RNA was converted to double stranded cDNA using a synthesis kit (Gibco) except that T-7-(dT)24 oligomer (Genset Corp.) was used. The double stranded cDNA was isolated with the GeneChip® Sample cleanup module.
Label biotin
Label protocol Target RNA was prepared according to protocols in the Affymetrix GeneChip® Expression Analysis technical manual (Affymetrix, Santa Clara, CA). In vitro synthesis of biotin-labeled cRNA was completed with Enzo BioArray HighYield RNA Transcript Labeling Kit (Affymetrix). In vitro transcription clean up was completed over an RNeasy spin column (Qiagen). Labeled cRNA mixed with fragmentation buffer was incubated at 94°C for 35 minutes. Final RNA concentration in fragmentation buffer ranged from 0.5-1.1 μg/μL. Visual confirmation of isolation and fragmentation was completed with agarose gel electrophoresis.
 
Hybridization protocol Labeled cRNA was hybridized to GeneChip® Test3 arrays and Murine Genome U74Av2 microarrays (Affymetrix). GeneChip® hybridization, washing and scanning was performed by the University of WI –Biotechnology Center, Gene Expression Center (University of WI, Madison) utilizing all Affymetrix protocols and procedures. Washing and streptavidin-phycoerythrin staining was completed on a GeneChip Fluidics station 400 (Affymetrix).
Scan protocol GeneChips were scanned with HP 2500 GeneArray Scanner and signal output analysis completed with MAS5.0 (Affymetrix).
Description See other fields.
Data processing Signal output analysis completed with MAS5.0 (Affymetrix). For statistical analysis arrays were compiled and processed with EBarrays, a statistical analysis package in the comprehensive R archive network.
 
Submission date Jun 18, 2007
Last update date Aug 14, 2011
Contact name Gary Splitter
E-mail(s) [email protected], [email protected]
Organization name University of Wisconsin - Madison
Department Pathobiological Sciences
Lab Dr. Gary Splitter
Street address 1656 Linden Dr
City Madison
State/province WI
ZIP/Postal code 53706
Country USA
 
Platform ID GPL81
Series (2)
GSE8385 Host RAW264.7 macrophage transcript profile following Brucella melitensis, B. neotomae, and B. ovis infections
GSE8403 RAW264.7 macrophages infected with Brucella abortus, B. melitensis, B. neotomae, and B. ovis

Data table header descriptions
ID_REF
VALUE Signal intensity using MAS5.0 (see Affymetrix Literature)
ABS_CALL Absolute call of presence (P), absence (A) or marginal (M) generated by an Affymetrix decision matrix for each gene
DETECTION P-VALUE p-value indicating the significance level of the detection call

Data table
ID_REF VALUE ABS_CALL DETECTION P-VALUE
AFFX-MurIL2_at 50.9479 A 0.891021
AFFX-MurIL10_at 195.739 A 0.470241
AFFX-MurIL4_at 99.5853 A 0.216524
AFFX-MurFAS_at 312.307 P 0.0032123
AFFX-BioB-5_at 852.575 M 0.0542134
AFFX-BioB-M_at 891.282 P 0.00401721
AFFX-BioB-3_at 666.941 P 0.0200219
AFFX-BioC-5_at 2047.18 P 0.000753643
AFFX-BioC-3_at 1162.73 P 0.000581214
AFFX-BioDn-5_at 1396.12 P 0.0044838
AFFX-BioDn-3_at 8867.86 P 0.000856509
AFFX-CreX-5_at 16678.5 P 6.02111e-05
AFFX-CreX-3_at 24959.2 P 4.42873e-05
AFFX-BioB-5_st 15.6507 A 0.699394
AFFX-BioB-M_st 95.347 A 0.772364
AFFX-BioB-3_st 97.6946 A 0.834139
AFFX-BioC-5_st 92.7094 A 0.794268
AFFX-BioC-3_st 18.3497 A 0.760937
AFFX-BioDn-5_st 575.489 A 0.275146
AFFX-BioDn-3_st 498.417 A 0.0956669

Total number of rows: 12488

Table truncated, full table size 360 Kbytes.




Supplementary file Size Download File type/resource
GSM201972.CEL.gz 2.9 Mb (ftp)(http) CEL
GSM201972.CHP.gz 4.9 Mb (ftp)(http) CHP
Processed data included within Sample table
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap